Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22169620 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Vitamin K Supplementation in Patients on Hemodialysis
Conditions: End Stage Renal Failure on Dialysis;   Atrial Fibrillation
Intervention: Drug: vitamin K1
2 Completed Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients
Condition: CKD 5D, Hemodialysis
Intervention: Dietary Supplement: daily supplementation of MK-7 over 6 weeks

Indicates status has not been verified in more than two years